Xue & Zhang
FULL PAPER
4.40—4.62 (m, 1H), 4.35—4.42 (m, 1H), 4.31—4.33
(m, 2H), 4.23 (d, J=6.0 Hz, 1H), 4.11—4.14 (m, 1H),
1.47 (s, CH3, 3H), 1.43 (s, CH3, 3H), 1.32 (s, CH3, 3H),
1.31 (s, CH3, 3H); 13C NMR (CDCl3) δ: 150.51 (d, J=
7.0 Hz), 129.64, 125.22, 120.10 (d, J=5.0 Hz), 109.54,
108.78, 96.15, 70.53, 70.41, 70.39, 67.37, 66.69, 60.27,
25.89, 25.85, 24.88, 24.31; 31P NMR (CDCl3) δ:
-12.01. HRMS (ESI) calcd for C24H29O9PNa+ [M+
Na+] 515.1447, found 515.1472.
phenyl phosphate (6f) Colorless oil; 1H NMR
(CDCl3) δ: 7.32—7.35 (m, 4H), 7.23—7.30 (m, 4H),
7.15—7.20 (m, 2H), 4.44 (dd, J=4.4, 6.4 Hz, 1H), 2.24
(d, J=12.0 Hz, 1H), 2.04 (d, J=4.4 Hz, 1H), 1.67 (d,
J=14.0 Hz, 2H), 1.24—1.43 (m, 2H), 1.21 (t, J=3.6
Hz, 1H), 1.00—1.03 (m, 1H), 0.73—0.91 (m, 9H); 13C
NMR (CDCl3) δ: 150.68 (d, J=8.0 Hz), 129.55, 125.04,
120.15 (d, J=5.0 Hz), 120.05 (d, J=5.0 Hz), 120.00,
81.48 (d, J=7.0 Hz), 48.36 (d, J=7.0 Hz), 42.36, 33.82,
31.45, 25.36, 22.73, 21.81, 20.74, 15.49; 31P NMR
(CDCl3) δ: - 12.40; HRMS (ESI) calcd for
C22H29O4PNa+ [M+Na+] 411.1701, found411.1733.
(R)-Methyl 2-(2-chlorophenyl)-2-(diphenoxypho-
sphoryloxy) acetate (7g) Colorless oil; 1H NMR
(CDCl3) δ: 7.44—7.46 (m, 1H), 7.34—7.37 (m, 2H),
7.05—7.30 (m, 11H), 6.40 (d, J=9.6 Hz, 1H), 3.70 (s,
3H); 13C NMR (CDCl3) δ: 167.87 (d, J=6.0 Hz),
150.33 (d, J=8.0 Hz), 149.99 (d, J=7.0 Hz), 133.37,
132.36, 132.31, 130.59, 129.71, 129.54, 129.48, 129.37,
127.11, 125.33, 125.22, 120.13 (d, J=5.0 Hz), 119.87
(d, J=5.0 Hz), 74.83 (d, J=5.0 Hz), 52.78; 31P NMR
(CDCl3) δ: -12.70; HRMS (ESI) calcd for C21H18Cl-
O6PNa+ [M+Na+] 455.0427, found 455,0448.
Cholesterolyl diphenyl phosphate (2b)[5c] White
1
solid; m.p. 234—237 ℃; H NMR (CDCl3) δ: 7.32—
7.37 (m, 4H), 7.22—7.27 (m, 4 H), 7.16—7.21 (m, 2 H),
5.37 (d, J = 4.8 Hz, 1H), 4.43—4.47 (m, 1H),
2.42—2.44 (m, 2H), 0.68—2.03 (m, 41H); 13C NMR
(CDCl3) δ: 150.75 (d, J=7.0 Hz), 139.10, 129.69,
125.16, 123.33, 120.15 (d, J=5.0 Hz), 80.36 (d, J=7.0
Hz), 56.66, 56.14, 49.97, 42.32, 39.80, 39.76, 39.70,
39.52, 36.87, 36.39, 36.18, 35.77, 31.88 (d, J=6.0 Hz),
29.52, 29.52, 29.48, 28.20, 28.01, 24.26, 23.83; 31P
NMR (CDCl3) δ: -12.87; HRMS (ESI) calcd for
C39H55O4PNa+ [M+Na+] 641.3736, found 641.3755.
Dioscinyl diphenyl phosphate (3c) White solid;
m.p. 292—296 ℃; 1H NMR (CDCl3) δ: 7.32—7.36 (m,
4H), 7.21 — 7.24 (m, 4H), 7.16—7.19 (m, 2H),
5.35—5.37 (d, J=5.2 Hz, 1H), 4.0—4.20 (d, J=7.2 Hz,
2H), 3.40—3.42 (m, 1H), 3.80—3.41 (m, 1H),
2.42—2.44 (m, 2H), 2.00 (m, 2H), 0.79—1.87 (m, 32H);
13C NMR (CDCl3) δ: 150.63 (d, J=8.0 Hz), 139.03,
129.62, 125.10, 122.97, 120.06 (d, J=5.0 Hz), 109.16,
80.68, 80.13 (d, J=7.0 Hz), 66.75, 62.01, 56.31, 49.78,
41.53, 40.16, 39.68, 39.63, 39.59, 36.74, 36.43, 31.92,
31.75, 31.31, 31.27, 30.21, 29.40, 29.36, 28.73, 20.74;
31P NMR (CDCl3) δ: -12.82; HRMS (ESI) calcd for
C39H51O6PNa+ [M+Na+] 669.3321, found 669.3346.
2-(2-(2-Chloroethoxy)ethoxy)ethyl diphenyl
Diphenyl 2-(thiophen-2-yl)ethyl phosphate (8h)
Colorless oil; 1H NMR (CDCl3) δ: 7.32—7.36 (m, 4 H),
7.16—7.24 (m, 4 H), 6.95 (m, 1H), 6.86—6.94 (m, 1H),
4.44—4.49 (m, 2H), 3.21—3.25 (m, 2H); 13C NMR
(CDCl3) δ: 150.28 (d, J=7.0 Hz), 138.27, 129.58,
126.78, 125.84, 125.17, 124.06, 119.85 (d, J=5.0 Hz),
68.80 (d, J=6.0 Hz), 30.56 (d, J=7.0 Hz); 31P NMR
(CDCl3) δ: -12.04; HRMS (ESI) calcd for C18H17O4P-
SNa+ [M+Na+] 383.0483, found 383.0507.
Diphenyl prop-2-ynyl phosphate (9i)[5] Colorless
oil; 1H NMR (CDCl3) δ: 7.30—7.34 (m, 4H),
7.23—7.25 (m, 4H), 7.15—7.19 (m, 2H), 4.80—4.83
(dd, J=2.4, 10.8 Hz, 2H), 2.61—2.62 (m, 1H); 13C
NMR (CDCl3) δ: 150.38 (d, J=6.0 Hz), 129.86, 125.60,
125.59, 120.16 (d, J=5.0 Hz), 76.88 (d, J=7.0 Hz),
56.41, 56.36; 31P NMR (CDCl3) δ: -11.81; HRMS
(ESI) calcd for C15H13O4PNa+ [M+Na+] 311.0449,
found 311.0461.
1
phosphate (4d) Colorless oil; H NMR (CDCl3) δ:
7.29—7.33 (m, 4H), 7.21—7.23 (m, 4H), 7.14—7.18
(m, 2H), 4.34—4.39 (m, 2H), 3.67—3.72 (m, 8H),
3.56—3.58 (m, 2H); 13C NMR (CDCl3) δ: 150.33 (d,
J=7.0 Hz), 129.54, 125.13, 119.88 (d, J=5.0 Hz),
71.11, 70.39 (d, J=4.0 Hz), 69.64 (d, J=7.0 Hz), 67.92,
67.85, 42.57; 31P NMR (CDCl3) δ: -11.84; HRMS
(ESI) calcd for C18H22 O6ClPNa+ [M+Na+] 423.0740,
found 423.0764.
(1,2,4,6-Di-O-isopropylidene)-D-glucofranosyl
diphenyl phosphate (5e) [5b,5c] Colorless oil; 1H NMR
(CDCl3) δ: 7.16—7.35 (m, 10H), 5.78 (d, J=4.4 Hz,
1H), 5.02—5.05 (dd, J=3.6, 7.2 Hz, 1H), 4.63 (d, J=
3.6, 1H), 4.21—4.23 (m, 1H), 4.18—4.20 (m, 1H),
4.05—3.95 (m, 2H), 1.47 (s, CH3), 1.38 (s, CH3), 1.24
(s, CH3), 1.23 (s, CH3); 13C NMR (CDCl3) δ: 150.40 (d,
J=8.0 Hz), 129.70 (d, J=5.0 Hz), 125.52 (d, J=11.0
Hz), 125.41, 120.13 (d, J=4.0 Hz), 120.01 (d, J=5.0
Hz), 119.96, 112.31, 109.24, 83.12, 81.00, 80.94, 80.31
(d, J=8.0 Hz), 71.81, 67.01, 26.69, 26.54, 26.02, 24.95;
31P NMR (CDCl3) δ: -12.88. HRMS (ESI) calcd for
C24H29O9PNa+ [M+Na+] 515.1447, found 515.1460.
(1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexyl di-
tert-Butyl diphenyl phosphate (10j)[5c] Colorless
oil; 1H NMR (CDCl3) δ: 7.33—7.27 (m, 4H),
7.24—7.12 (m, 6H), 1.58 (s, 9H); 13C NMR (CDCl3) δ:
150.91 (d, J=8.0 Hz), 124.86, 120.14 (d, J=5.0 Hz),
85.80 (d, J=8.0 Hz), 30.0 (d, J=4.0 Hz); 31P NMR
(CDCl3) δ: - 12.30; HRMS (ESI) calcd for
C16H19O4PNa+ [M+Na+] 329.0919, found 329.0930.
Results and Discussion
Initial study was carried out by treating 1,2:5,6-di-O-
isopropylidene-α-D-glucofuranose as a model substrate
with diphenyl chlorophosphate (1 equiv.) and Et3N (1
equiv.) in the presence of the selected catalysts (10
mol%) in CH2Cl2 and the results are shown in Table 1.
The use of B(C6F5)3 as a catalyst afforded the expected
phosphorylated product in excellent yields after 30 min.
2
© 2012 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2012, XX, 1—4